GRUBER JAMES R. (Chief Financial Officer) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/12/2025ACC: 0001437749-25-037743
Officer· Chief Financial Officer
Since Apr 2022
+960.00
Net shares
Net buyer
$77.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
5.50K acquired · 4.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.54K
Price / share
$16.99
Trade value
$77.17K
% of position
2.1%
12/12/2025
220.25K→215.71K
Total
Net shares
−4.54K
Net value
-$77.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | F · Tax Withholding | −4.54K | $16.99 | $77.17K | 2.1% | 220.25K | 215.71K |
| Total | −4.54K | -$77.17K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.50K shares
Shares
+5.50K
Strike price
Held after
210.25K
Exercisable
—
12/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.50K shares | 12/11/2025 | A · Award | +5.50K | — | 210.25K |